Amy Abernethy, the president of product development and chief medical officer at Verily, a health care spinout of search giant Alphabet, will leave the company at the end of the first quarter to start a nonprofit aimed at changing the way the health care system collects data.
The company announced Abernethy’s move to employees on Tuesday.
Both Verily and Abernethy insist the company is well-positioned to move toward her vision — that changing clinical research can speed the development of new products. But from the outside, the move looks like one more sharp jerk for an organization that has spent eight years narrowing its focus and finding its mission.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect